全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

基于网络药理学和分子对接技术探讨“川芎–当归”治疗急性缺血性脑卒中的作用机制
Based on Network Pharmacology and Molecular Docking, the Mechanism of “Angelica sinensis-Chuanxiong” in Treating Acute Ischemic Stroke Was Analyzed

DOI: 10.12677/tcm.2024.139313, PP. 2091-2102

Keywords: 川芎,当归,急性缺血性脑卒中,网络药理学,分子对接,富集分析,信号通路
Chuanxiong
, Angelica sinensis, Acute Ischaemic Stroke, Network Pharmacology, Molecular Docking, Enrichment Analysis, Signalling Pathways

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:本文运用计算机网络药理学和分子对接技术,预测川芎–当归药对治疗急性缺血性脑卒中的作用机制。方法:通过TCMSP数据库筛选出川芎和当归的有效成分及相关靶点,通过检索GeneCard、OMIM、DrugBank和Disgenet数据库,获得相关目标。利用Venny2.1绘制韦恩图获取药物疾病共同靶点,将其输入Cytoscape3.9.1软件绘制“当归、川芎–共同靶点–急性缺血性脑卒中”网络图。运用STRING数据库及Cytoscape3.9.1软件构建蛋白相互作用PPI网络,通过DAVID数据库进行靶点本体(GO)、京都靶点与靶点组百科全书(KEGG)富集分析,用微生信做富集分析的气泡图。利用AutoDock软件对分子对接进行了验证,并用pymol软件对分子对接进行了可视化。结果:分析出当归、川芎治疗急性缺血性脑卒中的有效活性成分9个,且潜在作用靶点53个,关键作用靶点为JUN、ESR1、CASP3、PTGS2。结论:当归、川芎药对通过多种通路、多种有效活性成分、多种有效靶点、实现对于急性缺血性脑卒中的治疗。主要涉及钙信号通路、磷脂酰肌醇-3-激酶(Phosphatidylinositol 3-kinase, PI3K)-AKT通路等通路发挥治疗作用,为后续研究此药对治疗急性缺血性脑卒中的机制提供了理论支持。
Objective: In this paper, computer network pharmacology and molecular docking techniques were applied to predict the mechanism of action of Chuanxiong and Angelica sinensis in the treatment of acute ischaemic stroke. Methods: The active ingredients and related targets of Chuanxiong and Angelica sinensis were screened by TCMSP database, and the related targets were obtained by searching GeneCard, OMIM, DrugBank and Disgenet databases. The Venny2.1 Venn diagram was used to obtain the common targets of the drugs and diseases, and then entered into the Cytoscape 3.9.1 software to draw the network diagram of “Angelica sinensis and Rhizoma Ligustici Chuanxiong - common targets - acute ischaemic stroke”. The protein interaction PPI network was constructed by using STRING database and Cytoscape 3.9.1 software, and the gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were carried out through DAVID database, and the bubble diagrams of the enrichment analyses were made by using Microbiology Letter. The molecular docking was verified by AutoDock software and visualised by Pymol software. Result: Nine active ingredients and 53 potential targets of Angelica sinensis and Rhizoma Ligustici Chuanxiong in the treatment of acute ischemic stroke, and the key targets were JUN, ESR1, CASP3 and PTGS2. Conclusion: The pair of Angelica sinensis and Rhizoma Ligustici Chuanxiong can be used in the treatment of acute ischemic stroke through a variety of pathways, active ingredients and targets. The therapeutic effects of this drug on acute ischaemic stroke are mainly related to the calcium signaling pathway and the phosphatidylinositol 3-kinase (PI3K)-AKT pathway, which provides theoretical support for the subsequent study of the mechanism of this drug in the treatment of acute ischaemic stroke.

References

[1]  王增武, 马志毅, 薛素芳, 等. 基层冠心病与缺血性脑卒中共患管理专家共识2022[J]. 中国心血管病研究, 2022, 20(9): 772-793.
[2]  中国脑卒中防治报告编写组. 《中国脑卒中防治报告2021》概要[J]. 中国脑血管病杂志, 2023, 20(11): 783-793.
[3]  苏占清, 夏毅, 宁厚旭, 等. 急性脑梗死中医病因病机、辨证研究概述及简评[J]. 世界科学技术-中医药现代化, 2022, 24(6): 2481-2486.
[4]  刘亚鹭, 等. 川芎-当归药对有效成分在缺血性脑卒中应用的研究进展[J]. 华西药学杂志, 2018, 33(6): 660-663.
[5]  管咏梅, 蒋成, 臧振中, 等. 川芎挥发油化学成分、药理作用及临床应用研究进展[J]. 中成药, 2024, 46(3): 873-880.
[6]  牟春燕, 殷越, 沈子芯. 当归化学成分及药理作用研究进展[J]. 山东中医杂志, 2024, 43(5): 544-551.
[7]  李晓雨, 李双凤, 刘晓美, 等. 当归-川芎药对的化学成分、药理作用及临床应用研究进展[J]. 中草药, 2024, 55(4): 1415-1426.
[8]  马风伟, 邓青芳. 缺血性脑卒中病理生理机制及治疗对策研究进展[J]. 贵州师范大学学报(自然科学版), 2022, 40(6): 116-122.
[9]  陈元堃, 曾奥, 罗振辉, 等. β-谷甾醇药理作用研究进展[J]. 广东药科大学学报, 2021, 37(1): 148-153.
[10]  Chang, Z., Chen, C., Tsai, M., Chen, C., Alshetaili, A., Hsiao, Y., et al. (2023) The Elucidation of Structure-Activity and Structure-Permeation Relationships for the Cutaneous Delivery of Phytosterols to Attenuate Psoriasiform Inflammation. International Immunopharmacology, 119, Article 110202.
https://doi.org/10.1016/j.intimp.2023.110202
[11]  李俊, 李翠娟, 孙理军, 等. 基于网络药理学及分子对接技术探讨川芎-当归-白芍治疗干燥综合征的作用机制[J]. 现代中西医结合杂志, 2023, 32(22): 3153-3162.
[12]  吴力超, 李俊峰, 张婷婷, 等. 基于网络药理学和细胞实验探讨豆甾醇抗炎作用[J]. 中成药, 2022, 44(2): 609-615.
[13]  刘裕源, 任璐, 何红云, 等. JNK通过增强神经元自噬流提高大鼠缺血性脑卒中后的神经保护[J]. 中国生物化学与分子生物学报, 2021, 37(7): 967-973.
[14]  陈海, 李红燕, 王建, 等. 基于网络药理学分析牛黄治疗缺血性脑卒中的作用机制[J]. 医药导报, 2021, 40(6): 768-772.
[15]  张海燕, 都镇先, 孟欣, 等. 胱天蛋白酶3介导BAG3蛋白剪切的研究[J]. 中国医科大学学报, 2012, 41(7): 603-606.
[16]  Zhang, Z., Mei, Y., Xiong, M., Lu, F., Zhao, X., Zhu, J., et al. (2021) Genetic Variation of Inflammatory Genes to Ischemic Stroke Risk in a Chinese Han Population. Pharmacogenomics and Personalized Medicine, 14, 977-986.
https://doi.org/10.2147/pgpm.s320483
[17]  Karar, J. and Maity, A. (2011) PI3K/AKT/mTOR Pathway in Angiogenesis. Frontiers in Molecular Neuroscience, 4, Article 51.
https://doi.org/10.3389/fnmol.2011.00051
[18]  Zheng, T., Jiang, T., Ma, H., Zhu, Y. and Wang, M. (2024) Targeting PI3K/AKT in Cerebral Ischemia Reperfusion Injury Alleviation: From Signaling Networks to Targeted Therapy. Molecular Neurobiology, 1-20.
https://doi.org/10.1007/s12035-024-04039-1
[19]  Xu, J., Li, Y., Kang, M., Chang, C., Wei, H., Zhang, C., et al. (2023) Multiple Forms of Cell Death: A Focus on the PI3K/AKT Pathway. Journal of Cellular Physiology, 238, 2026-2038.
https://doi.org/10.1002/jcp.31087
[20]  Kma, L. and Baruah, T.J. (2021) The Interplay of ROS and the PI3K/AKT Pathway in Autophagy Regulation. Biotechnology and Applied Biochemistry, 69, 248-264.
https://doi.org/10.1002/bab.2104
[21]  程永杰, 赵子瑞, 李晓妮, 等. 朝鲜当归提取物对小鼠脑缺血-再灌注损伤神经的保护作用及其机制[J]. 医药导报, 2020, 39(1): 22-26.
[22]  杜旌畅, 程青青, 母昌会. 藁本内酯体外促进模拟缺血环境血管内皮细胞增殖研究[J]. 四川医学, 2020, 41(5): 463-467.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133